Evidence map›Paper›PMID 38912739›Full record

ReviewAmerican journal of physiology. Cell physiology2024

Syndecans in hematopoietic cells and their niches.

Matthew W Hagen, Nicollette J Setiawan, Kelsey A Woodruff, Christina M Termini

Erratum issuedAbstract readReview
In one paragraph

Review in American journal of physiology. Cell physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Heparan Sulfate Proteoglycans in Immunity.Proteoglycan research · 2026
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Matthew W HagenTranslational Science & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States.ORCID 0000-0002-9812-2262
Nicollette J SetiawanTranslational Science & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States.
Kelsey A WoodruffTranslational Science & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States.
Christina M TerminiTranslational Science & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States.ORCID 0000-0002-1831-1347

Funding

The role of Syndecan-2 in hematopoietic stem cell maintenance and regenerationK01DK126989 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TERMINI, CHRISTINA MARIE · 2021 to 2025
$719k
American Heart Association (AHA) 23CDA1039196Andy Hill Cancer Research Endowment Fund FY23-DR-01HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5K01DK126989NIDDK NIH HHS K01 DK126989
6 · The paper itself

Abstract

Heparan sulfate proteoglycans are a family of glycoproteins that modulate cell signaling by binding growth factors and changing their bioavailability. Syndecans are a specific family of transmembrane heparan sulfate proteoglycans that regulate cell adhesion, migration, and signaling. In this review, we will summarize emerging evidence for the functions of syndecans in the normal and malignant blood systems and their microenvironments. More specifically, we detail the known functions of syndecans within normal hematopoietic stem cells. Furthermore, we discuss the functions of syndecans in hematological malignancies, including myeloid malignancies, lymphomas, and bleeding disorders. As normal and malignant hematopoietic cells require cues from their microenvironments to function, we also summarize the roles of syndecans in cells of the stromal, endothelial, and osteolineage compartments. Syndecan biology is a rapidly evolving field; a comprehensive understanding of these molecules and their place in the hematopoietic system promises to improve our grasp on disease processes and better predict the efficacies of growth factor-targeting therapies.

Indexed as

Hematopoietic Stem CellsStem Cell NicheSyndecansAnimalsHematologic NeoplasmsHematopoiesisHumansSignal TransductionSyndecansbone marrow nichehematopoiesisleukemiaproteoglycansyndecan

Identifiers

PMID38912739
PMCPMC11427021

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.